MSN LIFE SCIENCES PRIVATE LIMITED – FDA 483, Sep 13, 2024
An FDA inspection of MSN Life Sciences Private Limited, Unit II, an API manufacturer in Chandampet, Telangana, India, revealed significant deficiencies in quality control and facility maintenance. The firm failed to thoroughly investigate out-of-specification (OOS) and out-of-trend (OOT) results, and its quality unit did not adequately review critical deviations or ensure proper investigation and resolution. Additionally, the production areas lacked adequate washing facilities with hot water for personnel.
ID · 9b43461c-7bc9-470b-a8fc-0908765ace9f
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.